Eli Health Raises $5M to improve Women’s Lifelong Health with Saliva-Based Continuous Hormone Monitoring Technology
Eli, Montreal-based healthcare technology company committed to enhancing women's lifelong health through saliva-based hormone testing, announced today that it has raised 5 million CAD in new capital to drive its next phase of growth.
"Hormones have an enormous impact on women's health. They are at the root of many conditions, transitions, and symptoms from puberty to…
Optimizing oncology care for better patient management
Imagine if we could enable better organization of cancer treatments to relieve already overburdened healthcare providers from administrative tasks. Gray Oncology Solutions recently developed a software solution to automate patients scheduling for oncology treatments based on their specific needs and care protocols.
Read the article
Arbutus Medical Secures $2.26 Million Financing to Scale Up Innovative Solution for Skeletal Traction and help Trauma Center ERs
February 13, 2023, VANCOUVER, BC – Arbutus Medical Inc., a medical device company developing innovative surgical drill technology and sterile-packed orthopaedic procedure kits, has announced a $2.26MM financing jointly led by Genome British Columbia and Vancouver-based health technology venture fund Nimbus Synergies.
Genome BC has initially invested $1.13 million with potential further funding…
Axelys et les regroupements sectoriels de recherche industrielle (RSRI) unissent leurs efforts pour propulser l’innovation québécoise au profit des centres de recherche, des entreprises et de la société.
Sur la photo de gauche à droite : Les personnes qui ont pu être présentes le jour de la signature de l’entente. Thierry St-Cyr, Diane Gosselin, Jean-François Pouliot, Gilles Déry, Marie-Pierre Ippersiel, Jesse Vincent-Herscovici. Les autres personnes signataires de l’entente : Madeleine Jean, Diane Côté, Mohammed Benyagoub, Alain Aubertin
Montréal, le 9 février 2023 - Axelys, la…
Communiqué de presse : Dévoilement Envisag
National initiative will help Canadian companies get AgeTech solutions into the hands of older adults, caregivers and health care providers
More than 100 new innovative projects over 5 years across Canada
Montreal, QC – January 25th – MEDTEQ+ and AGE-WELL are officially unveiling envisAGE, a large-scale pan-Canadian initiative whose mission is to catalyze Canada’s…
Government of Canada invests in MEDTEQ+ to fund groundbreaking technologies that will benefit Canada’s seniors and their families
Government of Canada invests in MEDTEQ+ to fund groundbreaking technologies that will benefit Canada’s seniors and their families
This investment will support Canadian companies in developing, commercializing and launching new technologies
Read the press release in French.
December 7, 2022 – Québec, Quebec
The Government of Canada is committed to investing in…
BeachheadTM 2nd Call for Innovation Proposals
Key dates
Opening date of the call:
Closing date of the call:
Contact
For questions regarding the call for proposals: Contact
Partners
Beachhead 2nd Call for Innovation Proposals
MEDTEQ+ and Brain Canada are teaming up to fund collaborative projects that tackle the challenges associated with mental illness across Canada with…
Health innovations showcase
Key dates
Webinar
Watch the replay of the webinar
Intention form
Deadline: April 10, 2023 - 4 p.m.
Funding application
Deadline: June 21, 2023 - 4 p.m.
Contact
Nguyen-Vi Mohamed
Conseillère senior, Vitrine d’innovations en santé Contact
Financial partner
Program description
Objectives
The initiative deployed by MEDTEQ+ is supported by the…
15-B AI tools to characterize and identify unstable atherosclerotic plaques (ATLANTIS)
15-B AI tools to characterize and identify unstable atherosclerotic plaques (ATLANTIS)
Summary Background:
Strokes and myocardial infarctions (MIs), caused by the rupture of unstable atherosclerotic plaques in the carotid and coronary arteries, are the leading causes of death world-wide. Current clinical guidelines recommend surgical interventions based solely on the degree of…
14-N Correlation between a new method for the detection of reproductive hormones in saliva and a reference method (ELISA or LC-MS/MS).
14-N Correlation between a new method for the detection of reproductive hormones in saliva and a reference method (ELISA or LC-MS/MS).
Summary Women's contraceptive needs have evolved. In 2016, 51% of Canadian women using hormonal contraception reported adverse effects . There is increasing concern about these adverse effects , resulting in a growing number of women seeking…